HRV vaccine

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Infections, Rotavirus

Phase 2

Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa

CompletedNCT00383903

GlaxoSmithKlineInfections, Rotavirus

Start: 2003-09-30End: 2004-09-30Updated: 2016-09-15

Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months

CompletedNCT00385320

GlaxoSmithKlineInfections, Rotavirus

Start: 2001-05-31End: 2003-04-30Updated: 2019-12-27

Related Papers

Efficacy of the human rotavirus vaccine RIX4414 in malnourished children.

2007-06-2953 citations